Tissue-based research in kidney cancer: current challenges and future directions

Sabina Signoretti, Gennady Bratslavsky, Frederick M. Waldman, Victor E. Reuter, John Haaga, Maria Merino, George V. Thomas, Michael R. Pins, Towia Libermann, John Gillespie, Joseph E. Tomaszewski, Carolyn C. Compton, Andrew Hruszkewycz, W. Marston Linehan, Michael B. Atkins

Research output: Contribution to journalArticle

Abstract

The past several years have seen unprecedented advances in the application of various therapeutic strategies for the treatment of patients with renal cancer. The availability of active immunotherapy, antiangiogenic therapy, and targeted therapy for this disease has brought front and center issues related to choosing the appropriate treatment for particular patient populations. It is increasingly evident that the most promising treatment selection strategies will incorporate identifying specific features of the tumor itself. To facilitate this move toward personalized medicine, it is critically important to establish some standard principles for renal cancer tissue collection, preparation, and analysis for translational research studies. In this article, we identify and discuss some critical issues related to tissue-based kidney cancer research. We focus on five major areas as follows: (a) surgical and image-guided techniques for tissue collection; (b) quality control of specimen collection, processing, storage, and review; (c) issues related to analysis of paraffin embedded tissues; (d) genomic studies; and (e) assessment of reproducibility of assays across institutions. In addition, some practical implementation strategies are proposed. Although many of the topics discussed are specific for renal cancer, several are also relevant to tissue based biomarker investigations in a broad array of malignancies.

Original languageEnglish (US)
Pages (from-to)3699-3705
Number of pages7
JournalClinical Cancer Research
Volume14
Issue number12
DOIs
StatePublished - Jun 15 2008
Externally publishedYes

Fingerprint

Kidney Neoplasms
Research
Therapeutics
Specimen Handling
Active Immunotherapy
Precision Medicine
Translational Medical Research
Quality Control
Paraffin
Direction compound
Neoplasms
Biomarkers
Population

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Signoretti, S., Bratslavsky, G., Waldman, F. M., Reuter, V. E., Haaga, J., Merino, M., ... Atkins, M. B. (2008). Tissue-based research in kidney cancer: current challenges and future directions. Clinical Cancer Research, 14(12), 3699-3705. https://doi.org/10.1158/1078-0432.CCR-07-4733

Tissue-based research in kidney cancer : current challenges and future directions. / Signoretti, Sabina; Bratslavsky, Gennady; Waldman, Frederick M.; Reuter, Victor E.; Haaga, John; Merino, Maria; Thomas, George V.; Pins, Michael R.; Libermann, Towia; Gillespie, John; Tomaszewski, Joseph E.; Compton, Carolyn C.; Hruszkewycz, Andrew; Linehan, W. Marston; Atkins, Michael B.

In: Clinical Cancer Research, Vol. 14, No. 12, 15.06.2008, p. 3699-3705.

Research output: Contribution to journalArticle

Signoretti, S, Bratslavsky, G, Waldman, FM, Reuter, VE, Haaga, J, Merino, M, Thomas, GV, Pins, MR, Libermann, T, Gillespie, J, Tomaszewski, JE, Compton, CC, Hruszkewycz, A, Linehan, WM & Atkins, MB 2008, 'Tissue-based research in kidney cancer: current challenges and future directions', Clinical Cancer Research, vol. 14, no. 12, pp. 3699-3705. https://doi.org/10.1158/1078-0432.CCR-07-4733
Signoretti S, Bratslavsky G, Waldman FM, Reuter VE, Haaga J, Merino M et al. Tissue-based research in kidney cancer: current challenges and future directions. Clinical Cancer Research. 2008 Jun 15;14(12):3699-3705. https://doi.org/10.1158/1078-0432.CCR-07-4733
Signoretti, Sabina ; Bratslavsky, Gennady ; Waldman, Frederick M. ; Reuter, Victor E. ; Haaga, John ; Merino, Maria ; Thomas, George V. ; Pins, Michael R. ; Libermann, Towia ; Gillespie, John ; Tomaszewski, Joseph E. ; Compton, Carolyn C. ; Hruszkewycz, Andrew ; Linehan, W. Marston ; Atkins, Michael B. / Tissue-based research in kidney cancer : current challenges and future directions. In: Clinical Cancer Research. 2008 ; Vol. 14, No. 12. pp. 3699-3705.
@article{66344516390947ec97b9a23c02055d92,
title = "Tissue-based research in kidney cancer: current challenges and future directions",
abstract = "The past several years have seen unprecedented advances in the application of various therapeutic strategies for the treatment of patients with renal cancer. The availability of active immunotherapy, antiangiogenic therapy, and targeted therapy for this disease has brought front and center issues related to choosing the appropriate treatment for particular patient populations. It is increasingly evident that the most promising treatment selection strategies will incorporate identifying specific features of the tumor itself. To facilitate this move toward personalized medicine, it is critically important to establish some standard principles for renal cancer tissue collection, preparation, and analysis for translational research studies. In this article, we identify and discuss some critical issues related to tissue-based kidney cancer research. We focus on five major areas as follows: (a) surgical and image-guided techniques for tissue collection; (b) quality control of specimen collection, processing, storage, and review; (c) issues related to analysis of paraffin embedded tissues; (d) genomic studies; and (e) assessment of reproducibility of assays across institutions. In addition, some practical implementation strategies are proposed. Although many of the topics discussed are specific for renal cancer, several are also relevant to tissue based biomarker investigations in a broad array of malignancies.",
author = "Sabina Signoretti and Gennady Bratslavsky and Waldman, {Frederick M.} and Reuter, {Victor E.} and John Haaga and Maria Merino and Thomas, {George V.} and Pins, {Michael R.} and Towia Libermann and John Gillespie and Tomaszewski, {Joseph E.} and Compton, {Carolyn C.} and Andrew Hruszkewycz and Linehan, {W. Marston} and Atkins, {Michael B.}",
year = "2008",
month = "6",
day = "15",
doi = "10.1158/1078-0432.CCR-07-4733",
language = "English (US)",
volume = "14",
pages = "3699--3705",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "12",

}

TY - JOUR

T1 - Tissue-based research in kidney cancer

T2 - current challenges and future directions

AU - Signoretti, Sabina

AU - Bratslavsky, Gennady

AU - Waldman, Frederick M.

AU - Reuter, Victor E.

AU - Haaga, John

AU - Merino, Maria

AU - Thomas, George V.

AU - Pins, Michael R.

AU - Libermann, Towia

AU - Gillespie, John

AU - Tomaszewski, Joseph E.

AU - Compton, Carolyn C.

AU - Hruszkewycz, Andrew

AU - Linehan, W. Marston

AU - Atkins, Michael B.

PY - 2008/6/15

Y1 - 2008/6/15

N2 - The past several years have seen unprecedented advances in the application of various therapeutic strategies for the treatment of patients with renal cancer. The availability of active immunotherapy, antiangiogenic therapy, and targeted therapy for this disease has brought front and center issues related to choosing the appropriate treatment for particular patient populations. It is increasingly evident that the most promising treatment selection strategies will incorporate identifying specific features of the tumor itself. To facilitate this move toward personalized medicine, it is critically important to establish some standard principles for renal cancer tissue collection, preparation, and analysis for translational research studies. In this article, we identify and discuss some critical issues related to tissue-based kidney cancer research. We focus on five major areas as follows: (a) surgical and image-guided techniques for tissue collection; (b) quality control of specimen collection, processing, storage, and review; (c) issues related to analysis of paraffin embedded tissues; (d) genomic studies; and (e) assessment of reproducibility of assays across institutions. In addition, some practical implementation strategies are proposed. Although many of the topics discussed are specific for renal cancer, several are also relevant to tissue based biomarker investigations in a broad array of malignancies.

AB - The past several years have seen unprecedented advances in the application of various therapeutic strategies for the treatment of patients with renal cancer. The availability of active immunotherapy, antiangiogenic therapy, and targeted therapy for this disease has brought front and center issues related to choosing the appropriate treatment for particular patient populations. It is increasingly evident that the most promising treatment selection strategies will incorporate identifying specific features of the tumor itself. To facilitate this move toward personalized medicine, it is critically important to establish some standard principles for renal cancer tissue collection, preparation, and analysis for translational research studies. In this article, we identify and discuss some critical issues related to tissue-based kidney cancer research. We focus on five major areas as follows: (a) surgical and image-guided techniques for tissue collection; (b) quality control of specimen collection, processing, storage, and review; (c) issues related to analysis of paraffin embedded tissues; (d) genomic studies; and (e) assessment of reproducibility of assays across institutions. In addition, some practical implementation strategies are proposed. Although many of the topics discussed are specific for renal cancer, several are also relevant to tissue based biomarker investigations in a broad array of malignancies.

UR - http://www.scopus.com/inward/record.url?scp=52449083473&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=52449083473&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-07-4733

DO - 10.1158/1078-0432.CCR-07-4733

M3 - Article

C2 - 18559586

AN - SCOPUS:52449083473

VL - 14

SP - 3699

EP - 3705

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 12

ER -